Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 (SU 4312) unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
2 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 258.00 | |
50 mg | In stock | $ 403.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 (SU 4312) unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS. |
Targets&IC50 | VEGFR:0.8 μM, PDGFR:19.4 μM |
Synonyms | SU 4312, NSC 86429 |
Molecular Weight | 264.32 |
Formula | C17H16N2O |
CAS No. | 5812-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (208.07 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SU4312 5812-07-7 Angiogenesis Tyrosine Kinase/Adaptors PDGFR VEGFR NSC86429 Inhibitor SU 4312 NSC 86429 inhibit Vascular endothelial growth factor receptor NSC-86429 Platelet-derived growth factor receptor SU-4312 inhibitor